Back to Archive
2006 Symposium Program
Nov. 17, 2006 (Friday)
Hilton Garden Inn Bridgewater, NJ
Registration
5:30 PM ~ 5:45 PM
Coordinators: Dr. Seong Kon Kim, Merck; Dr. Seongwoo Hwang, PTC; Dr. Changsun Lee, PTC
Opening Remarks
5:45 PM ~ 6:00 PM
KASBP President: Dr. Young-Choon Moon, PTC
Friday Technical Session
Organizers:Dr. Young-Choon Moon, and Dr. Sung Soo Kim
6:00 PM ~ 7:00 PM
“Current Policy of Science and Technology and Status of BioTechnology in Korea”
Mr. Seoklae Lee, Bioteam Director, Ministry of Science & Technology, S. Korea
“Current Status of Pharmaceutical Industry and Strategic Consideration in Korea”
Dr. Younjoo Park, Deputy Director, Ministry of Science & Technology, S. Korea
Dinner and Panel Discussion (I&II)
Organizers:Dr. Young-Choon Moon, and Dr. Sung Soo Kim
7:00 PM ~ 8:30 PM
“Pannel Discussion on Future Korean BioPharmaceutical Industry”
· Current trend of drug discovery and development
· Missing pieces in current Korean drug R&D process
Panel Discussion (III)
Organizers: Dr. Nan-Joo Suh, and Dr. Chongwoo Yu
8:30 PM ~ 9:00 PM
“Pannel Discussion on Future Korean BioPharmaceutical Industry”
· Development of young professional
Nov. 18, 2006 (Saturday)
Waksman Institute, Busch Campus, Rutgers University, Piscataway, NJ
Registration & Light Breakfast
9:00 AM ~ 9:30 AM
Coordinators: Dr. Seong Kon Kim, Merck; Dr. Seongwoo Hwang, PTC; Dr. Changsun Lee, PTC
Opening Remarks
9:30 AM ~ 9:40 AM
KASBP President: Dr. Young-Choon Moon, PTC
Program Chair: Dr. Kyoung Soon Kim, BMS
Saturday Morning Session (I)
Organizers: Dr. Kyoung Soon Kim, and Dr. SungTaek Lim
9:40 AM ~ 10:50 AM
“First Fusion Inhibitor, FUZEON: From Discovery to Market”
Dr. Myung Chul Kang, Chief Operating Officer, BioInfra, Inc
“Integrative Analysis of High Dimensional Gene Expression, Metabolite and Protein Data: Integromics”
Dr. Kwan R. Lee, Sr. Director, GlaxoSmithKline Pharmaceuticals R&D
Coffee Break
10:50 AM ~ 11:10 AM
Saturday Morning Session (II)
11:10 AM ~ 12:20 PM
“Forward chemical genetic approach identifies new role for GAPDH in insulin signaling”
Dr. Jaeki Min, New York University,
“Novel Allosteric Bcr-abl Kinase Inhibitors”
Dr. Tae Bo Sim, Senior Research Scientist, Dana-Farber Cancer Institute
Lunch Break
12:20 PM ~ 1:20 PM
Saturday Afternoon Session (I)
1:20 PM ~ 2:30 PM
“Identification of post translational modification on TOPORS and its characterization as a dual ubiquitin and sumo E3 ligase”
Hye-Jin Park, Rutgers University
“Towards a Successful Marriage of Organic Molecules: a Catalytic Approach”
Hahn Kim, Princeton University
Award Ceremony
2:30 PM ~ 2:50 PM
Saturday Afternoon Session (II)
2:50 PM ~ 4:40 PM
“The Discovery of JANUVIATM (Sitagliptin): Selective Dipeptidyl Peptidase IV Inhibitors for the Treatment of Type 2 Diabetes”
Dr. Dooseop Kim, Sr Research Fellow, Merck
“The rhPTH as a Therapy for Osteoporosis”
Dr. ChongHwan Chang, Executive VP, Green Cross, S. Korea
“Antibody-maytansinoid conjugates are activated in targeted cancer cells by lysosomal degradation and linker-dependent intracellularprocessing”
Dr. Peter Unnam Park, Senior Director, ImmunoGen Inc.